Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,994
datasets available to search
ShareScore release 0.9.0
Dataset results
1,994 results for “Mortality;”
Excess Mortality Resulting from COVID-19 in Turkey during 2020-2021
<p>Dataset about Excess Mortality Resulting from COVID-19 in Turkey during 2020-2021.</p>
Transcriptional memory of dFOXO activity in early adulthood delays late life mortality [ATAC-seq]
GEO Series GSE183540. Drosophila melanogaster. 12 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
The TIMP3/Apelin axis Regulates Atherosclerosis and Heart Metabolism leading to increased mortality in ApoE null Mice
GEO Series GSE53548. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Identification of Early and Intermediate Biomarkers for Acute respiratory distress syndrome (ARDS) Mortality by Multi-Omic Approaches
GEO Series GSE176529. Homo sapiens. 42 samples. Type: Methylation profiling by high throughput sequencing.
Thesis: Locate and understand the mortality risk of forest tree under climate change. A multi-scale approach combining statistical and mechanistic modeling
<p>Data and tables in chapters 2 and 3 of the thesis</p>
Dataset related to the article "Reduced Cardiorenal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction"
<p>This record contains raw data related to the article "Reduced Cardiorenal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction"</p> <p><strong>ABSTRACT</strong> ST-segment elevation myocardial infarction (STEMI) patients with diabetes mellitus<br> (DM) have higher in-hospital mortality than those without. Since cardiac and renal<br> functions are the main variables associated with outcome in STEMI, we hypothesized<br> that this prognostic disparity may depend on a higher rate of cardiac and<br> renal dysfunction in DM patients.<br> RESEARCH DESIGN AND METHODS<br> We retrospectively analyzed 5,152 STEMI patients treated with primary angioplasty.<br> Left ventricular ejection fraction (LVEF) and estimated glomerular filtration rate<br> (eGFR) were evaluated at hospital admission. The primary end point was in-hospital<br> mortality. A composite of in-hospital mortality, cardiogenic shock, and acute kidney<br> injury was the secondary end point.<br> RESULTS<br> There were 879 patients (17%) with DM. The incidence of LVEF £40% (30% vs. 22%),<br> eGFR £60 mL/min/1.73m2 (27% vs. 18%), or both (12% vs. 6%) was higher (P < 0.001<br> for all comparisons) inDMpatients. In-hospital mortality was higher inDMpatients<br> than in non-DM patients (6.1% vs. 3.5%; P = 0.002), with an unadjusted odds ratio<br> (OR) of 1.81 (95% CI 1.31–2.49; P < 0.001). However, DM was no longer associated<br> with an increased mortality risk after adjustment for cardiac and renal function (OR<br> 1.03, 95% CI 0.68–1.56; P = 0.89). A similar behavior was observed for the secondary<br> end point, with an unadjusted OR for DM of 1.52 (95% CI 1.25–1.85; P < 0.001) and<br> an OR after adjustment for cardiac and renal function of 1.07 (95% CI 0.85–1.36;<br> P = 0.53).<br> CONCLUSIONS<br> The study indicates that the increased in-hospital mortality and morbidity of DM<br> patients with STEMI is mainly driven by their underlying cardiorenal dysfunction.</p>
Dataset related to Study: "Age and comorbidity are crucial predictors of mortality in severe obstructive sleep apnoea syndrome".
<p><strong>ABSTRACT</strong>: The prognostic role of comorbidity in patients with severe obstructive sleep apnoea syndrome (OSAS) and their role for risk stratification remain incompletely studied and poorly defined. We studied 1,592 patients with severe OSAS diagnosed by polysomnography. The primary outcome was all-cause mortality. We used Poisson regression to estimate the standardized mortality ratio (SMR), compared with the general population. The association of comorbidities with all-cause mortality was assessed using multivariable Cox regression analysis. Then, we calculated pseudo-R² to measure the proportion of variation explained by the model. Finally, we applied recursive-partitioning analysis to cluster the patients into risk groups according to individual comorbidities. A total of 11,721 person-years of follow-up were examined during which 390 deaths (3.33 deaths/100 person-years) occurred. The median follow-up was 7 (4-10) years. The SMR was 1.47 (1.33-1.63). Age, sex, obesity, cardiovascular diseases (CVD), moderate-to-severe chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD) and malignancy were independently associated with mortality risk. The model had a C index of 0.811 and explained 63.2% of the variation in mortality risk. Recursive-partitioning analysis allowed distinguishing three clinical phenotypes differentially associated with mortality risk. The combination of CKD with CVDs or with moderate-to-severe COPD conferred the highest risk. The SMR was 2.56 (2.13-3.08) in the high-, 1.59 (1.37-1.85) in the intermediate-, and 0.91 (0.75-1.11) in the low-risk category. Severe OSAS is associated with increased risk for all-cause death. Age and comorbidity are crucial contributors to increased mortality in severe OSAS. Clustering patients according to comorbidities allows identifying clinically meaningful phenotypes.</p>
Data set from Machine learning to predict in-hospital mortality in covid-19 patients using computed tomography-derived pulmonary and vascular features
<p>Data set from Machine learning to predict in-hospital mortality in covid-19 patients using computed tomography-derived pulmonary and vascular features</p>
Data set from Machine learning to predict in-hospital mortality in covid-19 patients using computed tomography-derived pulmonary and vascular features
<p>Data Set from the study Machine learning to predict in-hospital mortality in covid-19 patients using computed tomography-derived pulmonary and vascular features</p>
Dataset related to article: "Machine learning to predict mortality after rehabilitation among patients with severe stroke"
<p>We provide the raw data used for the following article:</p> <ul> <li>Scrutinio D, Ricciardi C, Donisi L, Losavio E, Battista P, Guida P, Cesarelli M, Pagano G, D'Addio G.<br> <em>Machine learning to predict mortality after rehabilitation among patients with severe stroke.</em> "Sci Rep." 2020 Nov 18;10(1):20127.<br> doi: 10.1038/s41598-020-77243-3. PMID: 33208913; PMCID: PMC7674405.</li> </ul> <p> </p> <p><strong>Abstract:</strong> Stroke is among the leading causes of death and disability worldwide. Approximately 20–25% of stroke survivors present severe disability, which is associated with increased mortality risk. Prognostication is inherent in the process of clinical decision-making. Machine learning (ML) methods have gained increasing popularity in the setting of biomedical research. The aim of this study was twofold: assessing the performance of ML tree-based algorithms for predicting three-year mortality model in 1207 stroke patients with severe disability who completed rehabilitation and comparing the performance of ML algorithms to that of a standard logistic regression. The logistic regression model achieved an area under the Receiver Operating Characteristics curve (AUC) of 0.745 and was well calibrated. At the optimal risk threshold, the model had an accuracy of 75.7%, a positive predictive value (PPV) of 33.9%, and a negative predictive value (NPV) of 91.0%. The ML algorithm outperformed the logistic regression model through the implementation of synthetic minority oversampling technique and the Random Forests, achieving an AUC of 0.928 and an accuracy of 86.3%. The PPV was 84.6% and the NPV 87.5%. This study introduced a step forward in the creation of standardisable tools for predicting health outcomes in individuals affected by stroke.</p>
Ceratitis capitata mortality
<p>Dataset about the Ceratitis capitata insecticides mortality in laboratory condition.</p>
Mortality
<p>Pea aphid exposure aqueous extract of <em>A. inebrians</em> of insecticidal activities</p>
The effect of pulmonary hypertension on mortality and intensive care unit admission in patients with SARS-CoV-2 infection: a systematic review and meta-analysis
<p>Dataset & R script for all analyses performed.</p>
Mortality data from the Baja California peninsula of Mexico
<p class="x">A consistent finding from contemporary Western societies is that women outlive men. However, what is unclear is whether sex differences in survival are constant across varying socio-ecological conditions. We test the universality of the female survival advantage with mortality data from a 19<sup>th</sup> century population in the Baja California peninsula of Mexico. When examined simply, we find evidence for a male-biased survival advantage. However, results from Cox regression clearly show the importance of age intervals for variable survival patterns by sex. Our key findings are that males: 1) experience significantly lower mortality risk than females during the ages 15-30 (RR = 0.69), 2) are at a significantly increased risk of dying in the 61+ category (RR = 1.30), and 3) do not experience significantly different mortality risk at any other age interval (0-14, 31-45, 46-60). We interpret our results to stem from differing intrinsic and extrinsic risk-factors for sex-biased mortality across age intervals, highlighting the relevance of a lifecourse approach to the study of survival advantage. Ultimately, our results make clear the need to more broadly consider variability in mortality risk factors across time and place to allow for a clearer understanding of human survival differences.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.